Tibet Aim Pharm Inc - Asset Resilience Ratio

Latest as of September 2025: 26.45%

Tibet Aim Pharm Inc (002826) has an Asset Resilience Ratio of 26.45% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 002826 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥280.00 Million

≈ $40.97 Million USD Cash + Short-term Investments

Total Assets

CN¥1.06 Billion

≈ $154.93 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2023)

This chart shows how Tibet Aim Pharm Inc's Asset Resilience Ratio has changed over time. See 002826 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Tibet Aim Pharm Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002826 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥280.00 Million	26.45%
Total Liquid Assets	CN¥280.00 Million	26.45%

Asset Resilience Insights

Very High Liquidity: Tibet Aim Pharm Inc maintains exceptional liquid asset reserves at 26.45% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Tibet Aim Pharm Inc Industry Peers by Asset Resilience Ratio

Compare Tibet Aim Pharm Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Tibet Aim Pharm Inc (2014–2023)

The table below shows the annual Asset Resilience Ratio data for Tibet Aim Pharm Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CN¥-2.00 ≈ $-0.29	CN¥927.74 Million ≈ $135.76 Million	-3.59pp
2019-12-31	3.59%	CN¥30.00 Million ≈ $4.39 Million	CN¥835.41 Million ≈ $122.25 Million	+3.73pp
2015-12-31	-0.14%	CN¥-570.74K ≈ $-83.52K	CN¥397.70 Million ≈ $58.20 Million	-0.96pp
2014-12-31	0.82%	CN¥2.20 Million ≈ $321.93K	CN¥268.42 Million ≈ $39.28 Million	--

pp = percentage points

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$544.09 Million

CN¥3.72 Billion CNY

Market Cap Rank

#12084 Global

#3726 in China

Share Price

CN¥19.50

Change (1 day)

-0.10%

52-Week Range

CN¥10.78 - CN¥25.74

All Time High

CN¥32.76